共 46 条
[1]
Berkovich R(2014)Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis Ther Adv Neurol Disord 7 83-96
[2]
Agius MA(2015)Efficacy and safety of adrenocorticotropic hormone gel (Acthar Gel Arthritis Rheumatol 67 2848-2849
[3]
Aggarwal R(2016)) in refractory dermatomyositis or polymyositis [ACR/ARHP abstract 2363] J Immunol Clin Res 3 1025-1031
[4]
Marder G(2016)Six months’ treatment of moderately to severely active systemic lupus erythematosus with repository corticotropin injection: an extension of a single-site, open-label trial Lupus Sci Med 3 e000180-139
[5]
Loganathan P(2015)Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomized, controlled pilot study Ann Rheum Dis 74 10661067-1114
[6]
Fiechtner JJ(2015)The effect of adrenocorticotropin gel (HP Acthar Gel) in combination with MTX in newly diagnosed RA patients from a clinical and structural perspective Ann Rheum Dis 74 1066-1078
[7]
Montroy T(2012)HP Acthar Gel (repository corticotropin injection) as adjunctive therapy in patients with rheumatoid arthritis who have failed at least three biologic therapies with different modes of action Drug Des Devel Ther 6 133-102
[8]
Furie R(2016)Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series J Neurol Dis 4 292-279
[9]
Mitrane M(2016)HP Acthar Gel F1000 Res 4 1103-155
[10]
Zhao E(2015) in dermatomyositis and polymyositis treatment registry: an interim analysis Ann Rheum Dis 74 1077-12